Brain

IRLAB’s Mesdopetam Displays Antipsychotic Properties in an Advanced Model of Parkinson’s Disease Psychosis

GOTHENBURG, SE / ACCESSWIRE / March 19, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 19 March 2024 - IRLAB Therapeutics…

9 months ago

Zeto Successfully Completes SOC 2 Type II Audit for Its Cloud Platform, Demonstrating Commitment to Data Security

SANTA CLARA, CA / ACCESSWIRE / March 18, 2024 / Zeto, Inc., a commercial-stage medical technology company transforming EEG brain…

9 months ago

Aruna Bio to Participate in Upcoming Investor Conferences

BOSTON and ATHENS, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for…

9 months ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and Handsome Albert Einstein MIAMI, March…

9 months ago

Gain Therapeutics to Present at Public Ventures Discovery Day

Gain Therapeutics’ Former CEO and current Board Member Eric Richman to participate in fireside chat hosted by Public Ventures President…

9 months ago

Ibogaine By David Dardashti: Government Urged to Increase Funding for Quantum Electrodynamics Research

Exploring the Relationship Between Glial Cells and Electromagnetic Waves David Dardashti and Quantum Electrodynamic Ibogaine By David Dardashti supports quantum…

9 months ago

Glioblastoma Foundation to Be Official Charity Partner of the 2024 Los Angeles Marathon

DURHAM, NC / ACCESSWIRE / March 14, 2024 / The Glioblastoma Foundation is proud to be a charity partner for…

9 months ago

AlzeCure to Partake in Redeye Theme: Alzheimer on March 21

STOCKHOLM, SWEDEN / ACCESSWIRE / March 14, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

9 months ago

Hop On A Cure Announces Philanthropic Commitment to Houston Methodist to Support ALS Research

ATLANTA, GA / ACCESSWIRE / March 13, 2024 / A leading advocate in the fight against ALS, Hop On A…

10 months ago

NovaSight Announces Publication of CureSight(TM)’s Pivotal Study of One-Year Follow-Up Outcomes

Study Demonstrates That Patients Achieved Long-Term Visual Acuity Gains Following CureSight TreatmentAIRPORT CITY, ISRAEL / ACCESSWIRE / March 13, 2024…

10 months ago